Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Timolol for Infantile Hemangioma
NCT01685398Phase 3Completed
- Sponsor
- Mahidol University
- Start
- Sep 2012
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of timolol in infantile hemangioma (IH), sponsored by Mahidol University. Started Sep 2012; status: completed.
02
Drugs
timolol
03
Conditions
infantile hemangioma (IH)
Beyond the preview
Go deeper on NCT01685398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01685398.